1 | DVBCWRM1 ;ALB/CMM RESPIRATORY, MISC. DISEASES WKS TEXT - 1 ; 6 MARCH 1997
|
---|
2 | ;;2.7;AMIE;**12**;Apr 10, 1995
|
---|
3 | ;
|
---|
4 | ;
|
---|
5 | TXT ;
|
---|
6 | ;;A. Review of Medical Records:
|
---|
7 | ;;
|
---|
8 | ;;
|
---|
9 | ;;
|
---|
10 | ;;B. Medical History (Subjective Complaints):
|
---|
11 | ;;
|
---|
12 | ;; Comment on:
|
---|
13 | ;; 1. Fever and/or night sweats.
|
---|
14 | ;;
|
---|
15 | ;;
|
---|
16 | ;; 2. Weight loss or gain.
|
---|
17 | ;;
|
---|
18 | ;;
|
---|
19 | ;; 3. Daytime hypersomnolence.
|
---|
20 | ;;
|
---|
21 | ;;
|
---|
22 | ;; 4. Hemoptysis.
|
---|
23 | ;;
|
---|
24 | ;;
|
---|
25 | ;; 5. Describe current treatment such as anticoagulant, tracheostomy,
|
---|
26 | ;; CPAP, oxygen, or antimicrobial therapy.
|
---|
27 | ;;
|
---|
28 | ;;
|
---|
29 | ;; 6. If malignant disease, state initial treatment date, site of
|
---|
30 | ;; original tumor, type of tumor, types of treatment used, and
|
---|
31 | ;; date treatment is expected to end. If treatment has been
|
---|
32 | ;; completed, state date treatment was completed.
|
---|
33 | ;;
|
---|
34 | ;;
|
---|
35 | ;;C. Physical Examination (Objective Findings):
|
---|
36 | ;;
|
---|
37 | ;; Address each of the following as appropriate to the condition
|
---|
38 | ;; being examined and fully describe current findings:
|
---|
39 | ;; 1. Pulmonary Hypertension, RVH, cor pulmonale, or congestive
|
---|
40 | ;; heart failure.
|
---|
41 | ;;
|
---|
42 | ;;
|
---|
43 | ;; 2. Residuals of pulmonary embolism.
|
---|
44 | ;;
|
---|
45 | ;;
|
---|
46 | ;; 3. Respiratory Failure.
|
---|
47 | ;;
|
---|
48 | ;;
|
---|
49 | ;; 4. Evidence of chronic pulmonary thromboembolism.
|
---|
50 | ;;
|
---|
51 | ;;
|
---|
52 | ;; 5. If ankylosing spondylitis, is there restriction of the chest
|
---|
53 | ;; excursion and dyspnea on minimal exertion?
|
---|
54 | ;;
|
---|
55 | ;;
|
---|
56 | ;; 6. Describe all residuals of malignancy including those due to
|
---|
57 | ;; treatment.
|
---|
58 | ;;
|
---|
59 | ;;
|
---|
60 | ;;D. Diagnostic and Clinical Tests:
|
---|
61 | ;;
|
---|
62 | ;; 1. Pulmonary Function Tests, if indicated. When the results of
|
---|
63 | ;; pre-bronchodilator pulmonary function tests are NORMAL, post-
|
---|
64 | ;; bronchodilator studies are not required for VA evaluation
|
---|
65 | ;; purposes. IN ALL OTHER CASES, post-bronchodilator studies
|
---|
66 | ;; should be conducted unless contraindicated (because of allergy
|
---|
67 | ;; to medication, etc.) or if the veteran was on bronchodilators
|
---|
68 | ;; before the test and had taken his or her medication within a
|
---|
69 | ;; few hours of the study. An examiner who determines that a
|
---|
70 | ;; post-bronchodilator study should not be performed should
|
---|
71 | ;; provide an explanation of why not. If there is a disparity
|
---|
72 | ;; between the results of different pulmonary function tests
|
---|
73 | ;; (FEV-1, FVC, etc.), the examiner should indicate which test
|
---|
74 | ;; result is the best indicator of the veteran's level of
|
---|
75 | ;; pulmonary functioning.
|
---|
76 | ;; 2. If sleep apnea is suspected, order SLEEP STUDIES.
|
---|
77 | ;; 3. Chest X-ray if necessary to document sarcoidosis or other
|
---|
78 | ;; parenchymal disease.
|
---|
79 | ;; 4. Include results of all diagnostic and clinical tests conducted
|
---|
80 | ;; in the examination report
|
---|
81 | ;;
|
---|
82 | ;;
|
---|
83 | ;;E. Diagnosis:
|
---|
84 | ;;
|
---|
85 | ;;
|
---|
86 | ;;Signature: Date:
|
---|
87 | ;;END
|
---|